title: JPMorgan 25th annual healthcare conference. Pipelines from NovaCardia, Quark Biotech, Raven Biotechnologies and Serenex.
authors.affiliation: Thomson Scientific, Middlesex House, 34-42 Cleveland Street, London, W1T 4JE, UK. peter.robins@thomson.com
authors.forename: Peter
authors.initials: P
authors.lastname: Robins
mesh_terms: D058916:Adenosine A1 Receptor Antagonists; D001709:Biotechnology / Q000379:methods / Q000639:trends; D002318:Cardiovascular Diseases / Q000188:drug therapy; D003695:Delivery of Health Care / Q000379:methods* / Q000639:trends; D004232:Diuretics / Q000627:therapeutic use; D004345:Drug Industry / Q000379:methods* / Q000639:trends; D006801:Humans; D049990:Membrane Transport Modulators / Q000627:therapeutic use; D052016:Mucositis / Q000188:drug therapy; D013841:Thiazepines / Q000627:therapeutic use; D014970:Xanthines / Q000627:therapeutic use
chemical_list: D058916:Adenosine A1 Receptor Antagonists; D004232:Diuretics; D049990:Membrane Transport Modulators; D013841:Thiazepines; D014970:Xanthines; C109183:K201 compound; C073525:rolofylline